Dry Fruits & Nuts #1502414

• active antihelminthics, stops hatched insect larvae from growing or multiplication
• has brood spectrum activity with the advantage of single administration in many cases
• effective in most of soil transmitted helminthiases like ascariasis, hook worm infestations and trichuuriasis
• efficacious in operable, widespread or numerous cysts of e.granulosus in conditions of noncompliance to surgery
• in case of intestinal tapeworm & cysticercosis, causes the reduction or disappearance of cysts in 80-90% of patients
• better & efficacious treatment than mebendazole for soil transmitted hookworms

• ascaris/enterobius/trichuris/round worm: single dose of 400 mg for adults & children above 2 yrs. 200 mg for 1 2 years of age
• tape worm/strong.loidosis/h.nana: 400 mg daily for 3 consecutive days, repeat after 14 days
• neurocysticercosis: 15 mg/kg/day in 2 divided doses for 7 days along with corticosteroids (albendazole is started on day 3 of steroids)
• hydatid disease: 400 mg bd for 4 weeks, repeat after 2 weeks (if required) up to 3 courses. It is the preferred treatment for inoperable cases and before surgery
• giardiasis: 400 mg daily for 5 days

• single or mixed intestinal parasites
• round worm/whipworm
• hookworm/tapeworm
• pinworm/threadworm
• ascaris.

• leoisomer of ofloxacain having improved activity against strep pneumonia & other gm+ve & gm-ve bacteria
• offers many improved qualities over older quinolone agents
• retians excellent anti gram negative bacillary activity
• possesses improved anti gram positive bacillary activity
• possesses greater bioavailability and a longer serum half-life allowing for once-daily dosing
• provides rapid step-down i.e. To oral therapy, minimizing unnecessary hospitalization, decreases costs & improves patient quality of life
• offers shorter duration of therapy in chronic urninary tract infections (cuti)
• most suited for the treatment of multi-drug resistant tuberculosis having good safety profile with long term use

• respiratory tract infections
• community acquired pneumonia
• chronic bacterial prostatitis
• urinary tract infections
• pyelonephritis
• skin & soft tissue infections

ondansetron oral disintegrating tablets i.p

composition:-

each un-coated oral disintegrating table contains:-

ondansetron hcl i.p.

eq. To ondansetron 4mg

excipients q.s

colour : sunset yellow supra.

ketorolac tromethamine tablets ip.

composition :

each un-coated tablet contain :

ketorolac tromethamine i.p. 10 mg.

excipient q.s.

• effective histamine antalogue controls vertigo in patients of meniera's syndrome
• meniera's syndrome occurs when there is a buildup of fluid within the inner ear. This causes symptoms such as tinnitus (buzzing in the ear), deafness and vertigo (a spinning sensation often causing vomiting)
• betahistine works by reducing the amount of fluid in the inner ear and therefore relieve these symptoms

• vertigo
• meniere's syndrome
• dizziness
• tinnitus
• nausea
• headache accompanied by loss of hearing symptomatic
• vestibular vertigo.

• respiratory tract infections
• intra abdominal infections
• gynecological infections
• urinary tract infections
• dental infections

• completely & rapidly resolves infections
• excellent safety
• good clinical success rates up to 90%
• convenient dosage form high tissue penetration

• pneumonia
• sinusitis
• acute bronchitis
• rti
• pharyngitis / tonsilitis
• uti

• an immodulating agent & dmard
• inhibits pyrimidine synthesis by inhibiting dihydroorotate dehydrogenase enzymes activity
• shows antiinflammatory properties
• effective in animal models of athritis & other autoimmune diseases, allergy & transplantation
• has immunosuppressive characteristics, acts as an anti-proliferative agent & displays antiflammatory properties

• active rheumatoid arthritis
• psoriatic arthritis

• a safe & powerful analgesic, antipyretic & anti-inflammatory
• better tolerability in terms of asthmatics/allergic
• maintains analgesia for longer duration
• better gastrointestinal safety, better tolerated & has less potential for adverse reactions

• time tested & trusted analgesic/antipyretic
• shows synergistic efficacy in combination with nsaids in treatment of pain conditions
• ensures prompt relief from pain & fever

• arthritis
• tendinitis & bursitis
• ankylosing spondylitis
• musculo-skeletal injuries
• low back pain
• dysmenorrhoea
• orodental pain & inflammation

• proteolytic with anti-edemic properties, prevents swelling & fluid retention
• reduces extent of cheek swelling and pain intensity after tooth extraction
• effective for the post-operative reduction of swelling and pain relief
• treats breast pain, breast swelling & induration in 85.7% of the patients
• enhances the penetration of concomitant drugs

• post-surgical inflammation
• breast engorgement
• tooth extraction
• pericoronitis

• a non-steroidal anti-inflammatory drug (nsaid) for reducing inflammation
• also reduces pain as an analgesic in conditions such as arthritis or acute injury
• inhibits cox for decreasing prostaglandins in the epithelium of the stomach, making it more sensitive to corrosion by gastric acid

• paracetamol is usually classified along with nonsteroidal anti-inflammatory drugs
• inhibits cycloxygenase (cox), an enzyme responsible for the production of prostaglandins, which are important mediators of inflammation, pain & fever

• a muscle relaxant. Works by blocking nerve impulses (or pain sensations) that are sent of brain
• used together with rest & physical therapy to treat skeletal muscle conditions such as pain or injury

• rheumatoid arthritis
• spondylarthritis
• osteoarthritis
• ankylosing spondylitis
• gout attacks
• sports injuries.

• orally active cephalosporin with a broad spectrum of antibacterial activity
• resistant to hydrolysis by many beta-lactamases
• single dose of cefizxime (400 to 800 mg) is as effective as ceftriaxone (250 mg im) in uncomplicated gonorrhea
• more effective than amoxicillin for acute otitis media caused by h. Influenzo
• highly active against h. Influenzoe, strep. Pneumonia, strep-pyogens

• h.influenzae: 100%
• ear infections: 97%
• uti: 96 %

• uncomplicated urinary tract infections
• otitis media/pharyngitis/tonsillitis
• acute exacerbations of chronic bronchitis
• uncomplicated gonorrhea

cefpodoxime proxetil dispersible tablets.

each un-coated flavoured dispersible tablet contain :

cefpodoxime proxetil 100 mg.

olanzapine tablets.

each uncoated tablet contain :

olanzapine 10 mg.

DIVALPROEX SODIUM DELAYED RELEASE TABLETS IP.

COMPOSITION :

Each enteric coated tablet contain :

Divalproex sodium 500 mg.

etamsylate & tranexamic acid tablets

composition :

each un-coated tablet contains :

etamsylate b.p. 250mg.

tranexamic acid i.p. 250mg.

excipients q.s.

methycobalamin tablets.

each film coated tablet contain :

methycobalamin 1500 mcg.

excipients q.s.

used for methylcobalamin tablet is a naturally occurring and pure form of vitamin b12. It is taken to regulate certain vital bodily functions like cell multiplication, blood formation, and protein synthesis. It is used to treat vitamin b12 deficiency in people with pernicious anemia.

piracetam tablets.

composition :

each film-coated tablets contain :

piracetam i.p 800 mg.

excipient q.s.

deflazacort tablets

composition :

each un-coated tablet contain :

deflazacort 6 mg.

CEFPODOXIME PROXETIL & POTASSIUM CLAVULANATE TABLETS.

Each film-coated tablet contain :

Cefpodoxime Proxetil 200 mg.

Potassium Clavulanate 125 mg.

betahistine dihydrochloride tablets.

each un-coated tablet contain :

betahistine dihydrochloride 8 mg.

betahistine dihydrochloride tablets.

each un-coated tablet contain :

betahistine dihydrochloride 16 mg.

ARTEMETHER & LUMEFANTRINE TABLETS

COMPOSITION :

Each uncoated tablet contain :

Artemether I.P. 80mg.

Lumefantrine 480mg.

Excipients q.s.

ofloxacin tablets i.p.

composition :

each film-coated tablet contain :

ofloxacin i.p. 400 mg.

excipient q.s.

ACICLOVIR TABLETS.

Each un-coated tablet contain :

Aciclovir 400 mg.

ACICLOVIR TABLETS.

Each uncoated tablet contain :

Aciclovir 800 mg.

citicoline sodium tablets.

each film coated tablet contain :

citicoline sodium

eq. To citicoline 500 mg.

excipient q.s.

composition :

each enteric-coated tablet contain :

divalproex sodium i.p.

eq. To valproic acid 500 mg.

excipient q.s.

etoricoxib tablets i.p.

composition :

each film-coated tablet contain :

etoricoxib i.p. 60 mg.

excipient q.s.

etoricoxib tablets i.p.

composition :

each film-coated tablet contain :

etiricoxib i.p. 90 mg.

excipient q.s.

cefixime & potassium clavulanate tablets.

composition :

each film-coated tablet contain :

cefixime i.p.

eq. To anhydrous cefixime 200 mg.

potassium clavulanate i.p.

(as potassium clavulanate dilute i.p)

eq. To clavulanic acid 125 mg.

excipient q.s.

Albendazole & Ivermectin Chewable tablets.

Albendazole 400 mg.

Ivermectin 6 mg.

terbinafine tablets usp 250mg.

composition :

each uncoated tablet contain :

terbinafine hydrochloride usp

equivalent to terbinafine 250mg.

faropenem sodium tablets.

composition :

faropenem sodium 200 mg.

• directly inhibits pge2 secretion at the site of inflammation
• stimulates the synthesis of the extracellular matrix of human articular cartilage
• an nsaid with greater cox-2 specificity when compared to diclofenac sodium

• well known antipyretic and analgesic
• relieves mild to moderate body pain

• time tested anti-fibrinolytic, anti-oedemic agent

• arthritis
• lumbago
• lower back pain
• thrombophlebitis
• post-episiotomy pain
• inflammatory conditions of ent
• bruises due to sports injuries
• traumatic swellings
• post surgical swelling
• ankylosing spondylitis

• low dose-a better choice
• diclofenac potassium is rapidly & well absorbed at low dose & is consistent with rapid onset of action of the drug
• superior to diclofenac sodium: in gastric tolerability
• comparable efficacy to etoricoxib (in osteoarthritis)
• etoricoxib 60 mg is comparable in efficacy to diclofenac 50 mg. T.d.s.
• paracetamol
• a time tested & trusted analgesic/antipyretic combined for synergistics action

• arthritis
• post operative pain
• dental pain
• low back pain
• dysmenorrhoea

• Anti aging protection against degenerative diseases
• Slow down the aging process of skin cells and tissues
• Helps repair damaged skin cells and accelerates wound healing
• Helps protect skin cells from harmful UV rays, air pollution and cigarette smoke
• Essential for protein and DNA synthesis to keep skin, hair and nail health in top form improves the body's resistance to stress
• Promotes good muscle rone of digestive system
• Promotes physical growth & improves lost appetite

• Age related skin problems
• Acne & Wounds Healing
• Convalescence
• Impaired digestion
• Sunburns
• General debility
• Stress / Weakness.

• possesses rapid onset of maximal acid suppression with greater antisecretory effect over a 24-hr period
• shows greater inhibition of gastric acid secretion than omeprazole
• produces rapid inhibition of h.pylori compared with omeprazole & lansoprazole, main ulcer causing agent
• reduces the frequency & intensity of heart burn associated with ulcerative oesophagitis in gerd

• only prokinetic with anti-emetic action

• gastroesophageal reflux disease
• functional dyspepsia
• erosive esophagitis
• post-operative nausea & vomiting.

• Most Important nutrients in reducing risk of osteoporosis
• Contains highest amount of elemental calcium compared to other forms
• Balances the calcium & minerals intake in body
• Improves the uptake of supplemental calcium in blood
• Promotes bonemineralisation
• Can control risk of Bone fractures
• Decreases bone Loss & Menopause
• Increases Intestinal Calcium absorption
• Improves bone resorption and conserve bone mass
• Vital for foetal growth
• Stimulates bone formation, bone mineralization and preserves bone mass

• Post-menopausal Osteoporosis
• Drug Induced Osteoporosis
• Senile Osteoporosis
• Pregnancy & Lactation.

AZITHROMYCIN DISPERSIBLE TABLETS

Each uncoated flavoured dispersibletablet contain:-

Azithromycin Dihydrate I.P.

eq. to Azithromycin Anhydrous 100mg.

Excipient q.s.

ETAMSYLATE 500MG. TABLETS

Each un-coated tablet contain :

Etamsylate B.P. 500mg.

Excipients q.s.

Dosage : As directed by the physician.

aceclofenac sustained released tablets.

composition :

each un-coated sustained released tablet contain :

aceclofenac i.p. 200 mg.

excipient q.s.

aceclofenac serratiopeptidase tablets.

composition :

each film-coated tablet contains :

aceclofenac i.p. 100 mg.

serratiopeptidase i.p. 15 mg.

(as enteric coated granules)

(eq. To 30.000 enzymatic activity units)

excipient q.s.

methylprednisolone tablets.

composition :

methylprednisolone 4 mg.

methylprednisolone tablets.

composition :

each un-coated tablet contain :

methylprednisolone 16 mg.

escitalopram oxalate tablets.

each film coated tablet contain :

escitalopram oxalate 5 mg.